BackBlueprint Medicines Overview

Blueprint Medicines Research & Development

Research & Development expenses for BPMC.

Quarterly R&D Expenses

$91.89M
↑ 10.2% YoY

As of Mar 31, 2025

Annual R&D Expenses (TTM)

$345.13M
↓ 13.65% YoY

Trailing 12 months ending Mar 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin